glutathione injection parkinson's disease Gene therapy and cell-based regeneration in care Insights into therapeutic approaches for

GSTM2 contains two main functional domains, GST-binding (N-terminal) and C-terminal domains (Supplementary Fig

In 10 patients with severe COVID-19 that were given plasma with neutralizing titres greater than 1:640 (200 ml) at a median of 16.5 days after disease onset, viraemia was no longer detected and clinical parameters improved within 3 days 78

Patients with advanced HGSOC frequently present with severe symptoms, including ascites, gastrointestinal symptoms, and systemic weakness, which significantly impact the quality of life of patients ( The standard treatment protocol for HGSOC typically involves combination chemotherapy utilizing platinum-based drugs (such as cisplatin or carboplatin) in conjunction with paclitaxel

LZ17H110001, and LY14H110002